Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)

Active

Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institutes of Health, under the Department of Health and Human Services, is seeking support for the continuation of the George M. O’Brien Urology Cooperative Research Centers Program. This initiative, categorized as a U54 clinical trial optional forecast, is designed to foster multi-disciplinary research and diverse collaborations both within and outside the centers to serve as a national resource for the urology research community. The program is associated with NAICS code 541715 and was posted on September 10, 2025. Interested parties can contact Deepak Nihalani for further information regarding this opportunity.

General Info

Continuation of George M. O’Brien Urology Centers supporting collaborative, multi-disciplinary urology research nationwide.

Agency

Department Of Health And Human Services → National Institutes Of Health

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedSep 10

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → National Institutes Of Health

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health

Office AddressUSA

Contacts

Deepak Nihalani

contact@example.gov

+1 (555) 000-0000

Full Description

Show more

This concept seeks support for continuation of the NIDDK George M. O’Brien Urology Cooperative Research Centers (U54). The Urology Cooperative Research Centers foster impactful, multi-disciplinary research through diverse collaborations within and outside the Centers and serve as a national resource for the urology research community.

Similar Contracts

Same NAICS industry code

AI/ML Algorithm Development

POSTED

about 19 hours ago

DEADLINE

Research, Development, Test and Evaluation (RDT&E)This subcontract opportunity, titled Research, Development, Test and Evaluation (RDT&E), is issued by the Department of Defense through the W6QK Acc-Apg agency. The project focuses on conducting scientific research and experimental development to support prime contractors on Army and DoD initiatives. The scope of work encompasses basic, applied, and exploratory research, as well as modeling, simulation, and prototyping and fabrication support. To be successful, the contractor must possess advanced simulation software and dedicated prototyping and fabrication facilities to deliver research findings, simulation models, prototypes, and comprehensive test reports. The performance of this contract will take place at Aberdeen Proving Ground, zip code 21005. The opportunity was posted on October 16, 2026, with a response deadline set for November 12, 2026, at 4:59 PM. The work is categorized under NAICS code 541715, reflecting its focus on research and experimental development within the natural sciences and engineering.

POSTED

about 19 hours ago

DEADLINE

Call 03 M-DASH - Joint All Domain Persistent Adaptive Collaborative Technologies II (JADPACT II)

Solicitation # FA238426SB007

The Multi-Decision Advantage Sprint for Human Machine Teaming (M-DASH) event is a technical effort under the Joint All Domain Persistent Adaptive Collaborative Technologies II (JADPACT II) program, managed by the Air Force Research Laboratory. The project focuses on developing Human-Machine Teaming concepts and AI/automation capabilities to provide Battle Managers with decision advantage, defined as the ability to make better and timelier decisions than an adversary. This unrestricted solicitation, identified as FA2384-26-S-B007, seeks innovative industry solutions to support the Advanced Battle Management System (ABMS) Transformational Model. The event is scheduled to take place from January 25, 2027, to February 5, 2027, in Las Vegas, Nevada, with a total estimated program cost of 600,000 dollars and a maximum award of 100,000 dollars per selected offeror. The government anticipates awarding Firm Fixed Price contracts, though it reserves the right to use other instruments such as grants or Other Transaction agreements. Key requirements for eligibility include a CMMC Level 1 Self assessment and adherence to AFRLI 61-113 for science and technology protection. Success is defined by the delivery of a working Minimum Viable Product and associated lessons learned, with a single payment issued upon receipt of deliverables via WAWF in PIEE. Proposals must be submitted electronically by October 21, 2026, and must include signed Privacy Act forms for all participating individuals. While the program is unclassified, contractors must strictly follow DoDI 5200.48 for the protection of Controlled Unclassified Information.

FA2384 USAF Afmc Afrl Pzl Afrl Rakh

POSTED

about 19 hours ago

DEADLINE

R--AREMP AND WATER SAMPLE ANALYSIS

Solicitation # 140L4326Q0124

Solicitation 140L4326Q0124, issued by the Bureau of Land Management Oregon State Office, seeks a firm fixed-price commercial service contract for the analysis of 165 water samples for the AREMP Program. The scope of work requires the analysis of Total Nitrogen and Total Phosphorus using alkaline persulfate digestion methods, specifically adhering to Lachat QuikChem and EPA standards. The period of performance is scheduled from October 31, 2026, to March 31, 2027, with a required laboratory turnaround time of 60 days from the receipt of samples. This acquisition is set aside for Women-Owned Small Businesses, Economically Disadvantaged Women-Owned Small Businesses, and 8(a) participants under NAICS code 541715. The government will award the contract to the responsible offeror determined to be most advantageous based on price and past performance. Quotations must be submitted in two parts, consisting of a price section and a non-price section that includes details on three similar projects completed as a prime contractor within the last three years. Technical requirements are stringent, necessitating a QAPP-style validation plan, specific Method Detection Limit studies per 40 CFR 136.6, and an ongoing quality control plan. Payment will be processed electronically through the Invoice Processing Platform System. Multiple amendments have been issued to clarify analytical methods, update the NAICS code, and extend the quotation deadline to October 21, 2026.

Oregon State Office

POSTED

about 19 hours ago

DEADLINE

Mild Traumatic Brain Injury (mTBI) Blast Injury Prevention Standards Request for Information

Solicitation # CB4_SW_mTBI_RFI

The Army Medical Resources Acq Activity, specifically the USAMRDC and the Department of War Blast Injury Research Coordinating Office in collaboration with The MITRE Corporation, has issued a Request for Information regarding Mild Traumatic Brain Injury blast injury prevention standards. This initiative aims to identify existing and emerging injury criteria, thresholds, standards, and models to inform the Military Health System Blast Injury Prevention Standards Recommendation process. The primary goal is to gather biomedically valid data, such as dose response curves and injury thresholds, to improve health hazard assessments, survivability assessments, and the development of protection systems for service members exposed to explosive weapons. This notice is issued solely for information and program planning purposes and does not constitute a formal solicitation for proposals. In accordance with FAR 15.201(e), responses are not considered offers and cannot be accepted to form a binding contract, nor will the government provide reimbursement for costs associated with participating. Interested parties from industry, academia, and other federal agencies are encouraged to submit relevant publications, reports, and images through a specific online submission process. The primary point of contact for this effort is Contract Specialist Skylar Wells, and the response deadline is November 3, 2026.

Army Medical Resources Acq Activity

POSTED

about 19 hours ago

DEADLINE

Aircraft Defensive Electro-optical Protection Technologies (ADEPT)

Solicitation # FA2377-26-R-B011

The Aircraft Defensive Electro-optical Protection Technologies (ADEPT) program, solicitation FA2377-26-R-B011, is a one-step solicitation issued by the Air Force Research Laboratory (AFRL) under the Multi-Spectrum Defensive Electronic Warfare (MSDEW) Basic ARA. With a total estimated value of 74,633,000.00 USD, the program seeks to develop pre-emptive and reactive countermeasure solutions in the electro-optical spectrum, including directed energy and expendable solutions, to protect U.S. aircraft and aircrew in contested environments. The effort is divided into two technical areas: Hardware and Executable Analysis of Threats (HEAT), which focuses on the exploitation of foreign EO-guided threat hardware and software, and Advanced Countermeasure Engineering (ACE), which provides scientific and engineering support for threat characterization and digital model development. Proposals are due by November 9, 2026, and must be submitted via a DoD SAFE link, for which requests must be made by November 6, 2026. Submissions must include separate technical/management and cost/business volumes for each technical area. Technical proposal page limits are 15 pages for Technical Area 1 and 20 pages for Technical Area 2, with a 10-page limit for the Statement of Work. Awards will be based on a Peer or Scientific Review evaluating technical understanding, approach, potential to advance the state of the art, and transition potential, with cost realism serving as a second-order priority. The contract utilizes a Cost Plus Fixed Fee arrangement for experimentation and evaluation, with performance primarily located at Wright Patterson AFB, Ohio. Offerors must meet CMMC Level 2 (Self) compliance and adhere to strict Controlled Unclassified Information (CUI) handling requirements.

FA2377 USAF Afmc Afrl Pzl Afrl Ryks

POSTED

about 19 hours ago

DEADLINE

ADVANCED RESEARCH ANNOUNCEMENT (ARA) TITLE: CHARACTERIZATION AND ASSESSMENT FOR SPACE DOMAIN AWARENESS (SDA)

Solicitation # FA875024S7005

The Department of the Air Force, through the Air Force Research Laboratory (AFRL) Rome Research Site, issued Advanced Research Announcement (ARA) FA8750-24-S-7005 to solicit research for the design, development, and testing of technologies supporting Space Domain Awareness (SDA) and Space Superiority. The effort focuses on high-performance computational SDA, specifically targeting intelligent tasking, multi-source data fusion, automated pattern learning, and high-fidelity satellite modeling to create integrated, predictive capabilities. The total estimated funding for the ARA is approximately 99 million dollars, with individual awards typically ranging from 1 million to 10 million dollars and lasting up to 48 months. Awards may be issued as FAR-based procurement contracts or Other Transactions (OT), with the potential for successful prototypes to transition into follow-on production contracts. The solicitation was structured as a two-step process, initially accepting white papers to determine technical merit and relevance before inviting formal proposals. Evaluation criteria focused equally on overall scientific and technical merit and the offeror's related experience with the Air Force or Joint DoD partners. Requirements included strict adherence to security standards such as NISPOM and specific disclosures regarding foreign influence and organizational conflicts of interest. However, according to Amendment 3, this ARA was officially cancelled and closed on September 9, 2025, and no further white papers are being accepted.

FA8750 Afrl Rik

POSTED

about 19 hours ago

DEADLINE

in over 2 years

ACC-DTA Ground Maneuver Commercial Solutions Opening (CSO)

Solicitation # W912CH-26-S-0001

The ACC-DTA Ground Maneuver Commercial Solutions Opening (CSO), solicitation W912CH-26-S-0001, is a streamlined acquisition initiative authorized under DFARS Subpart 212-70. Its primary objective is to rapidly procure innovative commercial products, services, and non-developmental items to enhance the development, integration, and sustainment of ground vehicle systems. The program utilizes a multi-phased competitive process—typically involving solution briefs, presentations, and commercial solution proposals—to expedite the delivery of critical technologies that support Army modernization and operational readiness. Awards may be structured as fixed-price or fixed-price incentive fee contracts, utilizing FAR Part 12 commercial procedures, non-FAR transaction agreements under 10 U.S.C. 4022, or Cooperative Agreements under 31 U.S.C. 6305. The scope of the CSO is broad and flexible, with various Areas of Interest (AoIs) added through 2028. Key initiatives include the TIGER Readiness program for the Abrams Main Battle Tank AGT 1500 engine, the Future Advanced Long-Range Common Optical/Netted-Fires Sensor (FALCONS) prototype with a funding ceiling of 24 million dollars, and the Light Tactical Trailer Heavy Chassis (LTT-HC). Other priorities include Counter-Unmanned Aircraft Systems (C-UAS) detection, Mobile Camouflage Systems, and additive manufacturing for component production. Evaluation is based on technical approach, performance schedule realism, and price affordability. To be eligible for award, vendors must be registered in the System for Award Management (SAM) with a Unique Entity ID and meet specific quality and security standards, including Buy American Act compliance and NIST SP 800-171 for handling controlled unclassified information.

POSTED

about 19 hours ago

DEADLINE

in about 2 years

Performance Enhanced Real-time Ground Environment (PEREGRINE) Sentry

Solicitation # SDA-SN-26-0016

The Space Development Agency is seeking capable sources for the Performance Enhanced Real-time Ground Environment (PEREGRINE) Sentry effort to support the resilient missile warning and tracking mission. The objective is to evolve the current PWSA ground segment into a secure, multi-tenant common development environment and a loosely-coupled, Modular Open Systems Architecture compliant ground segment framework. The selected lead platform integrator will be responsible for managing the software ecosystem framework lifecycle, ingesting third-party application developer capabilities, and executing a low-risk legacy capability transition under a strict do no harm paradigm. Technical requirements emphasize expertise in Hybrid Cloud, DevSecOps, Multi-Level Security, and Model-Based Systems Engineering, with the production phase utilizing a hub-and-spoke architecture spanning Commercial Cloud Enterprise resources and on-premises capabilities at Ops Centers. The anticipated acquisition strategy begins with an 18-month firm-fixed-price Other Transaction Agreement prototype contract focused on developing the cloud-native framework and environment. This may be followed by a production contract consisting of a three-year base period and two three-year option periods. Prime contractors must maintain a Top Secret facility clearance and are subject to potential Organizational Conflict of Interest restrictions, which may preclude them from developing mission applications integrated into the ecosystem. Responses to this sources sought notice, which are for informational purposes and not a formal solicitation, are due by October 30, 2026, and must be limited to thirteen pages excluding the cover page.

FA2401 Space Development Agency Sda

POSTED

about 19 hours ago

DEADLINE

Intrinsic Market Resilience (IMR)

Solicitation # DARPA-PS-26-138

Defense Advanced Research Projects Agcy

POSTED

about 19 hours ago

DEADLINE

in about 2 months

Space Environment Technologies and Science (SETS) Broad Agency Announcement (BAA) Call 004

Solicitation # FA945326RX012

FA9453 Afrl Rvk

POSTED

about 19 hours ago

DEADLINE

NGA - Boosting Innovative GEOINT - Science & Technology Broad Agency Announcement (BIG-ST BAA): Topic # 07 – Lidar Analysis for Surface & Environmental Reconnaissance (LASER)

Solicitation # HM047627XXXX

The National Geospatial-Intelligence Agency (NGA) is soliciting innovative research and development proposals through the Boosting Innovative GEOINT-Science and Technology (BIG-ST) Broad Agency Announcement (BAA), solicitation number HM047623BAA0001. This general solicitation focuses on three primary technical domains: Foundational GEOINT, Advanced Phenomenologies, and Analytic Technologies. While the BAA serves as a general announcement of research interests for Technology Readiness Levels 1 through 7, specific requirements and submission timelines are issued via separate Topic Calls. Awards may be granted as procurement contracts, grants, cooperative agreements, or Other Transaction Agreements. The current active effort is Topic 07, Lidar Analysis for Surface and Environmental Reconnaissance (LASER), which seeks to develop AI/ML workflows for the autonomous detection of man-made surface and subsurface objects using ICESat-2 and GEDI space lidar data. This Phase 2 effort has a budget of $854,000 over a 15-month period of performance, with an estimated start date of February 15, 2027. The project aims to advance technology from TRL 4 to TRL 5 or 6, requiring a probability of detection greater than 75 percent and positional accuracy within one meter for underwater targets and centimeter scale for above-ground targets. Key deliverables include a kick-off brief, AI/ML methodology reports, a final demonstration, and a comprehensive final report. Proposals must strictly adhere to the Appendix 2 template and include four volumes covering technical/management, cost/price, and security, along with required attachments such as a Statement of Work and Acquisition Security Review questionnaire. Security is a critical component, with requirements ranging from unclassified Controlled Unclassified Information (CUI) handling to Top Secret/SCI clearances and polygraph testing depending on the work's classification level. Evaluation is based on a conformance review followed by a scientific and technical review, where the government assigns confidence ratings to determine the most advantageous proposal. Administrative requirements include electronic invoicing via the Invoice Processing Platform and compliance with DFARS cybersecurity standards.

Attn: Ms S84 - Ocs

POSTED

about 19 hours ago

DEADLINE

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)The National Institutes of Health is seeking applicants to establish Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications. These centers will provide essential resources and testing services to the biomedical community to advance the development of genome editing technologies for treating human diseases. By collaborating with NIH-funded investigators, the centers will evaluate the efficacy and safety of delivery technologies, establish editing thresholds to minimize off-target effects, and determine feasibility within various model systems. The initiative emphasizes the creation of in vivo and in vitro research models, with a specific interest in new approach methodologies and human-biology-based models to complement traditional methods. Testing Centers are expected to develop standardized assays and operating procedures to ensure scientific rigor and reproducibility. While focusing on a limited number of initial projects, these centers will build adaptable core systems designed to support a wide range of diseases and offer fee-for-service resources on a local, regional, and national scale.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs)The National Institute on Aging, under the Department of Health and Human Services, intends to publish a Notice of Funding Opportunity for the Coordinating Center of the Claude D. Pepper Older Americans Independence Centers program. This center will act as a facilitator for site interactions and translate program objectives and findings for scientific and general audiences. The selected entity must possess significant scientific expertise in geriatrics and a proven track record of coordinating complex multi-site projects. This announcement serves as a forecast to allow potential applicants time to establish collaborations before the official solicitation is released. The funding opportunity will utilize the U24 activity code. Interested investigators with expertise in aging research are encouraged to prepare for the upcoming application process.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional)The National Institute on Alcohol Abuse and Alcoholism, under the Department of Health and Human Services, intends to issue a Notice of Funding Opportunity to continue the Collaborative Initiative on Fetal Alcohol Spectrum Disorders. This multidisciplinary research consortium focuses on a wide range of studies, including basic, clinical, translational, diagnostic, intervention, and prevention research aimed at addressing the lifelong physical, cognitive, and behavioral impairments caused by prenatal alcohol exposure. The program seeks to support high-priority needs such as improving early identification and diagnosis, validating interventions, and exploring the mechanisms of alcohol teratogenesis to reduce the incidence of these disorders. Successful projects must demonstrate strong integration with the broader consortium through the use of shared resources, coordinated data activities, and multidisciplinary expertise. This forecast indicates a research program where clinical trials are optional.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Centers for Research on Neglected Infectious DiseasesThe National Institute of Allergy and Infectious Diseases, under the National Institutes of Health, is establishing the Centers for Research on Neglected Infectious Diseases to combat communicable viral, bacterial, parasitic, and fungal infections. This initiative focuses on the epidemiology, pathogenesis, diagnosis, treatment, and prevention of parasitic neglected infectious diseases within endemic regions. By building sustainable in-country research capacity and expertise, the program aims to identify, contain, and mitigate these diseases at their source to protect global health and reduce the risk of spread within the United States. This opportunity is issued as a forecast by the Department of Health and Human Services and is governed by the Public Health Service Act and Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. Interested parties can coordinate with the Division of Microbiology and Infectious Diseases for further information. The program emphasizes a multidisciplinary approach to research and training to address the substantial morbidity and mortality associated with understudied infectious diseases.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)The National Institutes of Health, under the Department of Health and Human Services, is offering a Phased Innovation Award to advance innovative HIV prevention interventions. This funding opportunity utilizes a two-stage R61/R33 structure to move research from initial development and feasibility testing to larger-scale efficacy and implementation studies. The initial R61 phase focuses on the development, refinement, and pilot testing of novel strategies to address critical scientific and operational questions, ensuring readiness for expanded evaluation across diverse populations. Upon the successful completion of R61 milestones, the R33 phase provides support for expanded testing of interventions and implementation strategies. These studies may evaluate the scalability, sustainability, and clinical management of HIV prevention interventions, specifically including integrated approaches that address alcohol use and related comorbidities. Interested parties can contact the HIV/AIDS and Alcohol Research Program for further information.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)The National Institutes of Health is forecasting a Notice of Funding Opportunity to solicit applications for early to definitive clinical trials. This initiative seeks proposals testing a wide range of interventions, including drugs, devices, biologics, procedures, and behavioral or social interventions, provided they align with the research missions of the participating NIH Institutes, Centers, and Offices. The funding will utilize a bi-phasic, milestone-driven R61/R33 activity code with a maximum project period of seven years. The R61 phase focuses on planning activities, while the R33 phase supports the actual clinical trial. Although applications are not currently being accepted, this notice serves as an advance alert for investigators with expertise in trial design, implementation, and stakeholder engagement to begin developing collaborations and projects.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)The National Institute on Aging intends to issue a single U24 cooperative agreement award to support the continued operation and expansion of the Exceptional Longevity Data Management and Coordinating Center. Serving as the central hub for human longevity translational research, the center integrates deeply phenotyped cohorts and multi-omics datasets to enable cross-cohort analyses and collaborative research. Key responsibilities include data harmonization, the implementation of common data standards, and the management of the ELITE Portal, which provides the research community with secure access to analytical tools and cloud-based computational workspaces. The upcoming funding opportunity will require the Coordinating Center to expand its capabilities in artificial intelligence, machine learning, and the integration of diverse datasets across different species. Future objectives include the development of curated target knowledgebases for therapeutic targets, the enhancement of portal interoperability according to FAIR data principles, and the strengthening of community engagement through specialized training and workshops. This notice serves as a forecast to allow potential applicants to establish collaborations before the official solicitation is released.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Immune Drivers of Autoimmune DiseaseThe National Institute of Allergy and Infectious Diseases seeks to support the Immune Drivers of Autoimmune Disease network to investigate the triggers and early mechanisms of autoimmunity in humans. The primary goal is to develop tools for risk prediction and staging, identify pre-clinical immune mechanisms, and utilize artificial intelligence and big data to prevent autoimmune diseases. This initiative emphasizes the creation of preclinical cohorts and the use of remote recruitment and sampling to advance medical research. The network will be managed by a Coordinating Center responsible for data harmonization, sample sharing, and the administration of an Infrastructure Opportunity Fund for collaborative research projects. This forecast, issued by the National Institutes of Health under the Department of Health and Human Services, establishes a framework for shared infrastructure and steering committee oversight to identify common pathways and prevention opportunities.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)The National Institutes of Health, through the Department of Health and Human Services, is soliciting applications for the NLM Grants for Scholarly Works in Biomedicine and Health program. This initiative provides funding for the creation of book-length manuscripts and other integrative scholarly works, such as critical reviews and analytical syntheses, designed to benefit U.S. health professionals, scientists, and public health practitioners. The primary goal is to organize and disseminate biomedical and health-related knowledge to improve research, education, and clinical practice. This opportunity is listed as a forecast with a posted date of September 24, 2026. It specifically prohibits the use of clinical trials. Interested parties can contact the NLM Extramural Programs office for further information regarding the application process and program requirements.

Book Publishers

POSTED

DEADLINE

Partnerships for Advancing Development of Diagnostics for Infectious DiseasesThe National Institute of Allergy and Infectious Diseases, under the National Institutes of Health, is seeking to establish partnerships between academic or small business investigators and industrial partners to advance the translational development of diagnostic tests for infectious diseases. This initiative focuses on moving diagnostics that have already demonstrated proof-of-concept through the commercialization process by aligning researchers with experienced industry partners to de-risk development and ensure products are fit for purpose. The program will be supported by a science advisory board and NIAID oversight, incorporating annual meetings and workshops to facilitate collaboration and knowledge exchange. This effort is authorized under the Public Health Service Act and federal regulations to ensure that promising diagnostic technologies are successfully translated into tools for treating and preventing infectious diseases.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE)The National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, is forecasting the LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE) program. This initiative aims to bridge the gap between traditional clinical trial findings and real-world application by supporting collaborations on effectiveness trials, pragmatic trials, and hybrid effectiveness-implementation studies. The program focuses on the prevention and treatment of HIV, including associated coinfections and comorbidities, across all age groups and various points of care. The goal of the program is to advance cross-cutting research in epidemiology, implementation science, and clinical, behavioral, and social sciences. This effort aligns with the broader NIH mission to implement research advances in HIV/AIDS. The opportunity is authorized under the Public Health Service Act and relevant federal regulations, with administrative oversight provided by the Division of AIDS Epidemiology Branch.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Collaborative Centers in Children’s Environmental Health Research and Translation (P2C Clinical Trial Optional)The National Institutes of Health, under the Department of Health and Human Services, is seeking applications to establish a national network of Children's Environmental Health Research Translation Centers. These centers are designed to protect and improve children's health by developing scientific questions and public health interventions focused on translational research. A primary objective is to move evidence-informed biomedical findings into practical application for the wider community while mentoring a new generation of investigators in the field. Beyond research and translation, the program will function as a national resource to coordinate responses to emerging environmental exposures that impact children. The initiative emphasizes the creation of actionable strategies to prevent harm and ensure a healthy future for children through collaborative efforts within the environmental health community.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS